105 related articles for article (PubMed ID: 7973117)
1. Postoperative fibrin formation and visual outcome after pars plana vitrectomy.
Han DP; Wang Q; Hartz A; Jaffe GJ; Murray TG; Boldt HC; Arrindell EL; Coe E; Abrams GW; Mieler WF
Retina; 1994; 14(3):225-30. PubMed ID: 7973117
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for postvitrectomy fibrin formation.
Jaffe GJ; Schwartz D; Han DP; Gottlieb M; Hartz A; McCarty D; Mieler WF; Abrams GW
Am J Ophthalmol; 1990 Jun; 109(6):661-7. PubMed ID: 2346195
[TBL] [Abstract][Full Text] [Related]
3. Endophthalmitis after pars plana vitrectomy. The Postvitrectomy Endophthalmitis Study Group.
Cohen SM; Flynn HW; Murray TG; Smiddy WE
Ophthalmology; 1995 May; 102(5):705-12. PubMed ID: 7777268
[TBL] [Abstract][Full Text] [Related]
4. Tissue plasminogen activator for postvitrectomy fibrin formation.
Jaffe GJ; Abrams GW; Williams GA; Han DP
Ophthalmology; 1990 Feb; 97(2):184-9. PubMed ID: 2109297
[TBL] [Abstract][Full Text] [Related]
5. The lowest effective dose of tissue plasminogen activator for fibrinolysis of postvitrectomy fibrin.
Boldt HC; Abrams GW; Murray TG; Han DP; Mieler WF
Retina; 1992; 12(3 Suppl):S75-9. PubMed ID: 1455089
[TBL] [Abstract][Full Text] [Related]
6. Tissue plasminogen activator and penetrating keratoplasty.
Heidemann DG; Williams GA; Blumenkranz MS
Ophthalmic Surg; 1990 May; 21(5):364-5. PubMed ID: 2116614
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors in open eye injury managed with vitrectomy: retrospective study.
Globocnik Petrovic M; Lumi X; Drnovsek Olup B
Croat Med J; 2004 Jun; 45(3):299-303. PubMed ID: 15185422
[TBL] [Abstract][Full Text] [Related]
8. Hybrid 20/23-gauge pars plana vitrectomy for retained lens fragments after cataract surgery.
Barthelmes D; Alexander S; Mitchell P; Chandra J
Retina; 2012 Oct; 32(9):1749-55. PubMed ID: 22466486
[TBL] [Abstract][Full Text] [Related]
9. Treatment of postvitrectomy fibrin formation with intraocular tissue plasminogen activator.
Williams GA; Lambrou FH; Jaffe GA; Snyder RW; Green GD; Devenyi RG; Abrams GW
Arch Ophthalmol; 1988 Aug; 106(8):1055-8. PubMed ID: 3135790
[TBL] [Abstract][Full Text] [Related]
10. Visual outcomes after pars plana vitrectomy for epiretinal membranes associated with pars planitis.
Dev S; Mieler WF; Pulido JS; Mittra RA
Ophthalmology; 1999 Jun; 106(6):1086-90. PubMed ID: 10366075
[TBL] [Abstract][Full Text] [Related]
11. Pars plana vitrectomy, subretinal injection of tissue plasminogen activator, and fluid-gas exchange for displacement of thick submacular hemorrhage in age-related macular degeneration.
Haupert CL; McCuen BW; Jaffe GJ; Steuer ER; Cox TA; Toth CA; Fekrat S; Postel EA
Am J Ophthalmol; 2001 Feb; 131(2):208-15. PubMed ID: 11228297
[TBL] [Abstract][Full Text] [Related]
12. A comparison of visual results and complications in eyes with posterior chamber intraocular lens dislocation treated with pars plana vitrectomy and lens repositioning or lens exchange.
Sarrafizadeh R; Ruby AJ; Hassan TS; Williams GA; Garretson BR; Trese MT; Margherio RR
Ophthalmology; 2001 Jan; 108(1):82-9. PubMed ID: 11150269
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Postvitrectomy Fibrin Using Intravitreal Tissue Plasminogen Activator.
Al-Hashimi MR; Hardin J; Sallam AB
Retina; 2017 Sep; 37(9):e97-e98. PubMed ID: 28613218
[No Abstract] [Full Text] [Related]
14. [Treatment of intraocular fibrin formation with tissue plasminogen activator after vitrectomy].
Zhao P; Wang W
Zhonghua Yan Ke Za Zhi; 1995 Jul; 31(4):255-8. PubMed ID: 8745515
[TBL] [Abstract][Full Text] [Related]
15. Suprachoroidal hemorrhage during pars plana vitrectomy in traumatized eyes.
Mei H; Xing Y; Yang A; Wang J; Xu Y; Heiligenhaus A
Retina; 2009 Apr; 29(4):473-6. PubMed ID: 19174724
[TBL] [Abstract][Full Text] [Related]
16. LONG-TERM OUTCOMES OF 23-GAUGE PARS PLANA VITRECTOMY WITH INTERNAL LIMITING MEMBRANE PEELING AND GAS TAMPONADE FOR MYOPIC TRACTION MACULOPATHY: A Prospective Study.
Figueroa MS; Ruiz-Moreno JM; Gonzalez del Valle F; Govetto A; de la Vega C; Plascencia RN; Contreras I; Medina JL
Retina; 2015 Sep; 35(9):1836-43. PubMed ID: 25946689
[TBL] [Abstract][Full Text] [Related]
17. 23-gauge vitrectomy in 100 eyes: short-term visual outcomes and complications.
Lott MN; Manning MH; Singh J; Zhang H; Singh H; Marcus DM
Retina; 2008 Oct; 28(9):1193-200. PubMed ID: 18626419
[TBL] [Abstract][Full Text] [Related]
18. Treatment of postvitrectomy fibrin pupillary block with tissue plasminogen activator.
Jaffe GJ; Lewis H; Han DP; Williams GA; Abrams GW
Am J Ophthalmol; 1989 Aug; 108(2):170-5. PubMed ID: 2502924
[TBL] [Abstract][Full Text] [Related]
19. Pars plana vitrectomy for the management of retained lens material after cataract surgery.
Merani R; Hunyor AP; Playfair TJ; Chang A; Gregory-Roberts J; Hunyor AB; Azar D; Cumming RG
Am J Ophthalmol; 2007 Sep; 144(3):364-70. PubMed ID: 17632068
[TBL] [Abstract][Full Text] [Related]
20. Endophthalmitis after pars plana vitrectomy: Incidence, causative organisms, and visual acuity outcomes.
Eifrig CW; Scott IU; Flynn HW; Smiddy WE; Newton J
Am J Ophthalmol; 2004 Nov; 138(5):799-802. PubMed ID: 15531315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
